Safety evaluation of outpatient ifosfamide regimens in adult sarcoma patients
Overall, among sarcoma patients meeting the FHCC outpatient ifosfamide criteria, administration of ifosfamide in the outpatient setting is safe with considerable cost savings to the institution.
Authors
- Angel Liu
- Kevin K Cheng (ORCID: https://orcid.org/0009-0009-4367-7656)
- Mark Jao (ORCID: https://orcid.org/0000-0001-8693-4768)
- Vanessa C. Copeland (ORCID: https://orcid.org/0009-0003-9627-6748)
- Sandhya Vijapurapu
Institutions
- Fred Hutch Cancer Center (US)
Publication Details
- Journal
- Journal of Oncology Pharmacy Practice
- Published
- 2025-12-09
- DOI
- https://doi.org/10.1177/10781552251399903
- Primary Topic
- Chemotherapy-induced organ toxicity mitigation
- Type
- article
- Field-Weighted Citation Impact
- 0.00